GoodRx Holdings, Inc. Class A Common Stock
GDRXGoodRx Holdings, Inc. Class A (GDRX) is a healthcare technology company that provides consumers with free access to prescription drug price comparisons and discounts. Founded in 2011, it aims to make healthcare more affordable by helping users find lower-cost medication options through its digital platform, including websites and mobile apps. GoodRx collaborates with pharmacies and healthcare providers to offer savings and streamline the medication purchasing process.
Company News
Novo Nordisk launched its Wegovy weight loss pill in US pharmacies in December 2025 with competitive pricing starting at $149/month for self-pay patients. The pill demonstrated 17% average weight loss versus 3% for placebo. It's available through major retailers including CVS and Costco, as well as telehealth providers. Despite the positive produ...
Novo Nordisk announced a price reduction for Wegovy and Ozempic, offering a $199/month introductory rate for new self-pay patients, and lowering the standard monthly price from $499 to $349 to improve medication accessibility.
The telepharmacy market is projected to grow from $10.06 billion in 2024 to $21.89 billion by 2032, with a 10.23% annual growth rate. The market is driven by technological advancements, reducing healthcare disparities, and expanding digital pharmacy access, particularly in rural areas.
GoodRx announced a collaboration with Novo Nordisk to offer Ozempic and Wegovy pens at $499/month for eligible self-paying patients, expanding medication access and meeting growing demand for GLP-1 medications.
Sesame, a healthcare marketplace, is offering no-cost virtual healthcare appointments to Los Angeles residents affected by wildfires, including primary care, prescription refills, and mental health medication management.
